Article

A Caregiver's Perspective: Light Chain (AL) Amyloidosis Treatment

Author(s):

Susan Weisman

Susan Weisman, a light chain (AL) amyloidosis caregiver for her husband since 2009, touches on a few of her husband's treatments in an approximate timeline.

Susan Weisman, a light chain (AL) amyloidosis caregiver for her husband since 2009, touches on a few of her husband's treatments in an approximate timeline.

Related Videos
Experts' Perspectives: Top Stories in Cardiology for 2024
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orly Vardeny, PharmD: Finerenone for Heart Failure with EF >40% in FINEARTS-HF | Image Credit: JACC Journals
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Matthew Weir, MD: Prioritizing Cardiovascular Risk in Chronic Kidney Disease | Image Credit: University of Maryland
Related Content
Rushad Patell, MD | Credit: BIDMC
December 8th 2024

GLP-1 Receptor Agonists Could Reduce Stroke Risk in Type 2 Diabetes

Patrick Campbell
Diabetes Dialogue: News and Updates in Diabetes at AHA 2024
November 21st 2024

Diabetes Dialogue: News and Updates in Diabetes at AHA 2024

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Emerson C. Perin, MD, PhD, Medical Director, The Texas Heart Institute
December 5th 2024

Cell Therapy Gets RMAT Designation for HLHS, Improves Survival in Heart Failure With Reduced Ejection Fraction

Victoria Johnson
Kidney Compass default thumbnail with podcast logo and headshots of hosts Brendon Neuen and Shikha Wadhwani.
October 28th 2024

Kidney Compass: FLOW Insights from Kidney Week 2024, with Katherine Tuttle, MD

Brendon Neuen, MBBS, PhD Shikha Wadhwani, MD, MS
HCPLive Cardiology Month in Review: November 2024
December 1st 2024

Cardiology Month in Review: November 2024

Patrick Campbell Connor Iapoce
Obesity Drug MariTide Achieves Up to 20% Weight Loss in Phase 2 Trial | Image Credit: Amgen
November 26th 2024

Obesity Drug MariTide Achieves Up to 20% Weight Loss in Phase 2 Trial

Connor Iapoce
© 2024 MJH Life Sciences

All rights reserved.